---
title: "Pharmaceutical Grade Xanthan Gum Market, Global Outlook and Forecast 2025-2032"
datePublished: Sun Nov 09 2025 19:00:47 GMT+0000 (Coordinated Universal Time)
cuid: cmhs2woyw000002ky1q0udh9r
slug: pharmaceutical-grade-xanthan-gum-market-global-outlook-and-forecast-2025-2032-1

---

# Pharmaceutical Grade Xanthan Gum Market, Global Outlook and Forecast 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global Pharmaceutical Grade Xanthan Gum market size was valued at USD 287.5 million in 2024. The market is projected to grow from USD 312.8 million in 2025 to USD 498.6 million by 2032, exhibiting a CAGR of 6.9% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/235507/pharmaceutical-grade-xanthan-gum-market">
            https://www.24chemicalresearch.com/download-sample/235507/pharmaceutical-grade-xanthan-gum-market</a></b></div><br><p>
</p><p>Pharmaceutical Grade Xanthan Gum is a high-purity polysaccharide produced through fermentation of glucose or sucrose. As a multifunctional excipient, it serves as a thickener, stabilizer, and emulsifier in drug formulations. Its unique rheological properties, including pseudoplastic behavior and compatibility with various active pharmaceutical ingredients (APIs), make it indispensable in oral suspensions, topical creams, and controlled-release formulations.</p><p>
</p><p>The market growth is driven by increasing demand for specialized drug delivery systems and rising pharmaceutical production worldwide. With generic drugs accounting for 90% of US prescriptions (FDA data), formulators increasingly rely on xanthan gum's cost-effective performance. Recent innovations include its application in biologics stabilization and 3D-printed medications. In Q1 2025, CP Kelco introduced a new ultra-pure xanthan gum variant meeting stringent USP/NF specifications, signaling continued product development in this sector.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Expanding Pharmaceutical Industry to Fuel Demand for Xanthan Gum</strong></p><p>
</p><p>The global pharmaceutical industry's rapid expansion continues to drive demand for high-quality excipients like pharmaceutical grade xanthan gum. With the pharmaceutical market projected to reach $1.5 trillion by 2025 at a CAGR of approximately 6%, formulators increasingly rely on xanthan gum's unique properties for drug delivery optimization. This natural biopolymer's ability to maintain stability across pH ranges from 1 to 13 makes it particularly valuable for oral solid dosage forms and liquid suspensions. Recent innovations in controlled-release formulations have further amplified its adoption, with some modified-release drugs demonstrating 25-30% improved bioavailability when using xanthan gum as a matrix former.</p><p>
</p><p style="text-align:center"><strong>Rising Preference for Natural Excipients Accelerates Market Growth</strong></p><p>
</p><p>The shift toward natural and plant-based pharmaceutical ingredients continues to gain momentum, with xanthan gum emerging as a preferred alternative to synthetic thickeners and stabilizers. Regulatory agencies increasingly scrutinize synthetic excipients, creating opportunities for naturally derived alternatives. Pharmaceutical grade xanthan gum satisfies this demand while offering superior performance characteristics - including pseudoplastic behavior and exceptional suspending properties at concentrations as low as 0.1%. The global market for natural excipients is expected to grow at a CAGR of 6.8% through 2032, positioning xanthan gum as a key beneficiary of this trend.</p><p>

</p><p><strong>â¤ Recent formulations of pediatric suspensions now incorporate xanthan gum at 0.3-0.5% concentrations, demonstrating 40-50% improvement in homogeneity and sedimentation rates compared to conventional formulations.</strong></p><p>
</p><p>Additionally, expanding applications in ophthalmic preparations and topical creams have opened new growth avenues. The superior mucoadhesive properties of xanthan gum enhance ocular residence time by 2-3 fold in gel-based eye drops, driving adoption among ophthalmic drug developers.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Price Volatility of Raw Materials Challenges Cost Consistency</strong></p><p>
</p><p>While the market shows strong growth potential, price fluctuations in key raw materials - particularly corn and soybean substrates used in xanthan gum fermentation - create significant production cost challenges. Historical data indicates raw material costs can vary by 15-20% annually, directly impacting manufacturer margins. The fermentation process itself represents 60-70% of total production costs, making the industry particularly sensitive to agricultural commodity price movements. Some manufacturers report these fluctuations necessitate quarterly pricing adjustments to maintain profitability, complicating long-term contracts with pharmaceutical clients.</p><p>
</p><p><strong>Additional Constraints</strong></p><p>
</p><p><strong>Regulatory Compliance Costs</strong></p><p>
Meeting evolving pharmacopeial standards across regions requires substantial investment in quality systems. Compliance with current Good Manufacturing Practice (cGMP) guidelines can increase production costs by 12-15% compared to food-grade facilities, deterring some potential market entrants.</p><p>
</p><p><strong>Specialized Storage Requirements</strong></p><p>
Pharmaceutical grade xanthan gum demands tightly controlled humidity conditions (below 60% RH) to prevent clumping and ensure consistent performance. These specialized storage needs add 5-8% to distribution costs compared to conventional excipients.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Alternative Hydrocolloids Compete for Market Share</strong></p><p>
</p><p>The pharmaceutical excipient market features numerous alternative thickening agents vying for market share alongside xanthan gum. Modified celluloses, particularly hypromellose (HPMC) and carboxymethyl cellulose (CMC), have gained traction due to their consistent supply chains and well-characterized profiles. While xanthan gum offers superior viscosity at low concentrations, some formulators prefer alternatives for applications requiring thermal stability above 90°C, where cellulose derivatives demonstrate better performance. Certain emerging microbial polysaccharides also show promise, with clinical trials underway for gellan gum in extended-release matrix tablets.</p><p>
</p><p>Furthermore, the industry faces challenges in scaling production while maintaining stringent microbial quality standards. Fermentation-based production requires precise control of microbial cultures, with contamination risks adding 2-3% to production costs through additional quality control measures. The shift toward continuous manufacturing processes presents both opportunities and complexities in maintaining consistency across production batches.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Biosimilar and Orphan Drug Development Creates New Applications</strong></p><p>
</p><p>The rapid expansion of biosimilar and orphan drug development presents significant opportunities for pharmaceutical grade xanthan gum. Biosimilar formulations often require specialized excipients to match reference product performance, with xanthan gum finding increasing use as a stabilizer in monoclonal antibody preparations. Recent research indicates the biopolymer can improve protein stability during lyophilization, reducing aggregation by 15-20% compared to conventional stabilizers. Orphan drug formulations, which frequently require novel delivery approaches, increasingly incorporate xanthan gum in concentrations ranging from 0.1% to 1.2% for optimal rheological control.</p><p>
</p><p>Emerging markets also offer substantial growth potential, with pharmaceutical production expanding rapidly across Asia and Latin America. Local manufacturers increasingly adopt internationally compliant excipients as they target export markets, creating demand for high-quality xanthan gum. Regulatory harmonization efforts across Southeast Asian countries further facilitate market entry, with the ASEAN Common Technical Dossier requirements encouraging standardization of excipient specifications.</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Powder Segment Dominates Due to Superior Stability and Ease of Handling</strong></p><p>
</p><p>The pharmaceutical grade xanthan gum market is segmented based on type into:</p><p>
</p><p>Powder</p><p>
	</p><p>Subtypes: Food-grade, industrial-grade, and pharmaceutical-grade</p><p>Liquid</p><p>
	</p><p>Subtypes: Ready-to-use solutions and concentrates</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Thickening Agents Lead Market Findings Due to Extensive Use in Drug Formulations</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Thickening agents</p><p>Emulsion stabilizers</p><p>Foam enhancers</p><p>Release control agents</p><p>Others</p><p>
<strong>By End User</strong></p><p>
</p><p><strong>Pharmaceutical Companies Account for Largest Share Due to Drug Development Needs</strong></p><p>
</p><p>The market is segmented based on end user into:</p><p>
</p><p>Pharmaceutical companies</p><p>Biotechnology firms</p><p>Contract research organizations</p><p>Academic research institutions</p><p>
<strong>By Formulation</strong></p><p>
</p><p><strong>Oral Formulations Lead Consumption Due to High Usage in Suspensions and Tablets</strong></p><p>
</p><p>The market is segmented based on formulation into:</p><p>
</p><p>Oral formulations</p><p>
	</p><p>Subtypes: Tablets, capsules, suspensions</p><p>Topical formulations</p><p>Ophthalmic formulations</p><p>Others</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Established Brands and Emerging Players Compete Through Innovation and Strategic Expansion</strong></p><p>
</p><p>The pharmaceutical grade xanthan gum market features a dynamic competitive environment with both multinational corporations and specialized manufacturers vying for market share. <strong>CP Kelco</strong> and <strong>DuPont Danisco</strong> currently dominate the market, collectively holding approximately 35% of global revenue share in 2024. Their leadership stems from decades of experience in hydrocolloid production and established distribution networks across pharmaceutical markets worldwide.</p><p>
</p><p><strong>Cargill</strong> has emerged as a formidable competitor through strategic acquisitions and continuous R&amp;D investment. The company's 2023 expansion of its European production facility doubled its xanthan gum capacity, positioning it for stronger market penetration. Similarly, <strong>ADM</strong> has leveraged its global infrastructure to capture growing demand in emerging markets, particularly in Asia-Pacific regions where pharmaceutical manufacturing is rapidly expanding.</p><p>
</p><p>The market also encompasses several specialized Chinese manufacturers such as <strong>Fufeng Group</strong> and <strong>Meihua Group</strong> who compete on cost-effectiveness while gradually improving their product quality. These companies have significantly increased their exports to Western markets since 2022, benefiting from competitive pricing and improving regulatory compliance.</p><p>
</p><p>Recent developments indicate increasing market consolidation, with <strong>Jungbunzlauer</strong> acquiring two smaller producers in 2023 to expand its specialty ingredients portfolio. Meanwhile, <strong>Deosen Biochemical</strong> has differentiated itself through patented fermentation technologies that enable customized xanthan gum solutions for specific pharmaceutical applications.</p><p>
<strong>List of Key Pharmaceutical Grade Xanthan Gum Companies</strong></p><p>
</p><p>CP Kelco (U.S.)</p><p>DuPont Danisco (U.S.)</p><p>Cargill (U.S.)</p><p>ADM (U.S.)</p><p>Jungbunzlauer (Switzerland)</p><p>Fufeng Group (China)</p><p>Meihua Group (China)</p><p>Deosen Biochemical (China)</p><p>Hebei Xinhe Biochemical (China)</p><p>American International Chemical (U.S.)</p><p>Qingdao ICD Biochemistry (China)</p><p>
<strong>PHARMACEUTICAL GRADE XANTHAN GUM MARKET TRENDS</strong></p><p>
<strong>Increasing Demand for Drug Formulation Stabilizers Driving Market Growth</strong></p><p>
</p><p>The pharmaceutical grade xanthan gum market is experiencing robust growth due to its critical role as a stabilizer and viscosity enhancer in drug formulations. With <strong>global market valuation projected to reach $147 million by 2025</strong>, this biopolymer is becoming indispensable for oral suspensions, tablets, and topical applications. Recent technological advancements in fermentation processes have improved yield purity to <strong>over 99%</strong>, meeting stringent pharmacopeial standards. While North America currently dominates with <strong>38% market share</strong>, Asia-Pacific is emerging as the fastest-growing region, fueled by expanding pharmaceutical manufacturing capabilities in India and China.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Biopolymer Innovation in Controlled Drug Delivery</strong></p><p>
</p><p>Pharmaceutical companies are increasingly leveraging xanthan gum's unique pseudoplastic properties for developing time-release formulations. Its ability to form hydrogels that respond to pH changes makes it particularly valuable for <strong>gastro-retentive drug delivery systems</strong> and colon-targeted medications. The growing prevalence of chronic diseases requiring long-term medication regimens has accelerated R&amp;D investments in this segment, with <strong>over 120 active clinical trials</strong> currently investigating xanthan-based drug delivery platforms worldwide.</p><p>
<strong>Regulatory Approvals Expanding Application Scope</strong></p><p>
</p><p>Recent approvals by the FDA and EMA for xanthan gum in novel pharmaceutical applications have significantly broadened its commercial potential. The biopolymer's GRAS (Generally Recognized As Safe) status and compliance with USP/NF, EP, and JP pharmacopeias enable its use across multiple therapeutic categories. Furthermore, the European Medicines Agency's 2023 guidelines recognizing xanthan gum as a <strong>permissible excipient in pediatric formulations</strong> has opened new avenues for market expansion. These regulatory developments coincide with increased adoption in biosimilar formulations, where xanthan gum's stability attributes help maintain therapeutic equivalence.</p><p>
<strong>Sustainable Sourcing and Production Gaining Traction</strong></p><p>
</p><p>The industry is witnessing a marked shift toward sustainable production methods as environmental concerns intensify. Leading manufacturers are implementing <strong>closed-loop fermentation systems</strong> that reduce water consumption by 30-40% while improving yield consistency. Simultaneously, the exploration of alternative carbohydrate sources for xanthan production – including agricultural byproducts – is gaining momentum. This ecological focus aligns with the pharmaceutical sector's growing emphasis on green chemistry principles, making xanthan gum an increasingly attractive choice compared to synthetic alternatives.</p><p>
<strong>COVID-19 Pandemic Accelerating Market Dynamics</strong></p><p>
</p><p>The global health crisis has unexpectedly bolstered the xanthan gum market, particularly in vaccine adjuvant formulations and diagnostic reagents. Its rheological properties proved vital in stabilizing mRNA vaccine components during storage and transportation. Post-pandemic, the <strong>market grew at an unprecedented CAGR of 7.2%</strong> between 2020-2024,and this growth trajectory is expected to continue as pandemic preparedness initiatives drive stockpiling of excipient materials. However, supply chain vulnerabilities exposed during this period have prompted manufacturers to diversify production geographically and invest in strategic reserves.</p><p>

Regional Analysis: Pharmaceutical Grade Xanthan Gum Market
</p><p>

</p><p><strong>North America</strong> </p><p>
</p><p>North America represents one of the leading markets for pharmaceutical grade xanthan gum, supported by regulatory oversight from the U.S. Food and Drug Administration (FDA) and Health Canada. The region benefits from a strong pharmaceutical manufacturing base, significant R&amp;D investment, and the use of advanced excipients in drug formulations. The United States accounts for roughly 45% of the regional demand, with major applications in controlled-release formulations, suspending agents, and oral liquid dosages.</p><p>

<strong>Regulatory leadership</strong></p><p>
The FDA and Health Canada maintain strict standards for excipient safety and quality. Compliance with these regulations supports consistent demand for high-purity xanthan gum in pharmaceutical applications.</p><p>
<strong>Market dominance</strong></p><p>
The U.S. accounts for nearly half of North America’s xanthan gum consumption, driven by established drug manufacturing facilities and increasing adoption in biopharmaceutical and specialty formulations.</p><p>
<strong>Growth drivers</strong></p><p>
Rising adoption of controlled-release and targeted-delivery systems has increased the use of xanthan gum as a stabilizer and suspending agent. Ongoing R&amp;D and partnerships between pharmaceutical companies and excipient suppliers are expanding applications for high-purity and customized grades.</p><p>
<strong>Challenges</strong></p><p>
Market growth is moderated by high raw material costs, periodic supply chain fluctuations, and competition from alternative hydrocolloids such as guar gum and gellan gum. These pressures influence pricing, though long-term demand remains supported by innovation in drug delivery.

</p><p>
</p><p><strong>Europe</strong></p><p>
Europe's market thrives under the EU's GMP and REACH compliance requirements, with Germany and France leading consumption. The region emphasizes sustainable production, with manufacturers increasingly adopting fermentation-based processes to reduce environmental impact. Europe accounts for nearly 30% of global pharmaceutical xanthan gum demand, primarily for tablet binding and topical formulations. Brexit-related supply chain disruptions temporarily affected the UK market, but harmonized standards across the EU ensure steady growth. Emerging applications in nutraceuticals and medical nutrition products are expected to drive a 5.2% CAGR through 2032, with Western Europe remaining the revenue hub.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
Asia-Pacific is the fastest-growing market, projected to expand at 7.8% CAGR due to India and China's booming generic drug industries. China produces 60% of global xanthan gum but faces quality challenges in pharmaceutical-grade supply. Japan and South Korea lead in high-value applications, with strict PMDA and MFDS regulations ensuring premium product demand. While cost sensitivity limits adoption in some markets, increasing biosimilar production and healthcare investment across ASEAN countries are creating new opportunities. Local players like Fufeng Group are expanding production to meet both domestic needs and export demands for USP/EP compliant grades.</p><p>
</p><p><strong>South America</strong></p><p>
South America shows moderate growth potential, constrained by economic instability but supported by Brazil's developing pharmaceutical sector. ANVISA's evolving excipient regulations are gradually raising quality standards, though import dependency remains high at 75%. Argentina and Chile demonstrate increasing demand for xanthan gum in ophthalmic solutions and pediatric suspensions, but market penetration suffers from inconsistent raw material availability. The region's focus on local API production could indirectly benefit xanthan gum suppliers if policies encourage vertical integration in excipient manufacturing.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
This emerging market is witnessing growth through pharma sector investments in Saudi Arabia and UAE, where xanthan gum is used in halal-certified medicines and surgical lubricants. Limited local production capabilities mean 90% of supply is imported, primarily from Europe and Asia. South Africa serves as a regional hub for multinational pharmaceutical companies, driving quality-focused demand. While regulatory frameworks are still developing, the GCC's healthcare modernization initiatives and Africa's expanding generics market present long-term opportunities for compliant suppliers willing to navigate complex distribution networks.</p><p>
</p><p></p><p>

</p><p><strong>Key Report Takeaways</strong></p><p>
</p><p>
</p><p>
</p><p>
</p><p></p><p>
</p><p>
</p><p></p><p>
</p><p>
</p><p></p><p>
</p><p>
</p><p></p><p>
</p><p>
<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Pharmaceutical Grade Xanthan Gum, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Pharmaceutical Grade Xanthan Gum companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Pharmaceutical Grade Xanthan Gum Market?</strong></p><p>
</p><p><strong>-&gt;</strong> Global Pharmaceutical Grade Xanthan Gum market was valued at <strong>USD 287.5 million in 2024</strong> and is projected to reach <strong>USD 498.6 million by 2032</strong>, growing at a CAGR of 6.9%.</p><p>
<strong>Which key companies operate in Global Pharmaceutical Grade Xanthan Gum Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>CP Kelco, Cargill, ADM, DuPont Danisco, Fufeng Group, Deosen Biochemical, and Jungbunzlauer</strong>, with the top five companies holding approximately 62% market share in 2024.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand for specialized drug formulations, expansion of generic pharmaceuticals, and increasing applications in controlled-release medications</strong>. The market benefits from xanthan gum's unique rheological properties and FDA/EMA compliance.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; North America</strong> holds the largest market share (38% in 2024), while <strong>Asia-Pacific</strong> is projected to grow at the highest CAGR of 8.2% through 2032, driven by pharmaceutical manufacturing expansion in India and China.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>development of ultra-pure grades for biologics, application in 3D-printed medicines, and innovations in multi-functional excipient formulations</strong>. Recent product launches feature enhanced stability for mRNA vaccine applications.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/235507/pharmaceutical-grade-xanthan-gum-market">
            https://www.24chemicalresearch.com/reports/235507/pharmaceutical-grade-xanthan-gum-market</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
    1.1 Pharmaceutical Grade Xanthan Gum Market Definition<br />
    1.2 Market Segments<br />
        1.2.1 Market by Type<br />
        1.2.2 Market by Application<br />
    1.3 Global Pharmaceutical Grade Xanthan Gum Market Overview<br />
    1.4 Features & Benefits of This Report<br />
    1.5 Methodology & Sources of Information<br />
        1.5.1 Research Methodology<br />
        1.5.2 Research Process<br />
        1.5.3 Base Year<br />
        1.5.4 Report Assumptions & Caveats<br />
2 Global Pharmaceutical Grade Xanthan Gum Overall Market Size<br />
    2.1 Global Pharmaceutical Grade Xanthan Gum Market Size: 2022 VS 2032<br />
    2.2 Global Pharmaceutical Grade Xanthan Gum Revenue, Prospects & Forecasts: 2018-2032<br />
    2.3 Global Pharmaceutical Grade Xanthan Gum Sales: 2018-2032<br />
3 Company Landscape<br />
    3.1 Top Pharmaceutical Grade Xanthan Gum Players in Global Market<br />
    3.2 Top Global Pharmaceutical Grade Xanthan Gum Companies Ranked by Revenue<br />
    3.3 Global Pharmaceutical Grade Xanthan Gum Revenue by Companies<br />
    3.4 Global Pharmaceutical Grade Xanthan Gum Sales by Companies<br />
    3.5 Global Pharmaceutical Grade Xanthan Gum Price by Manufacturer (2018-2023)<br />
    3.6 Top 3 and Top 5 Pharmaceutical Grade Xanthan Gum Companies in Global Market, by Revenue in 2022<br />
    3.7 Global Manufacturers Pharmaceutical Grade Xanthan Gum Product Type<br />
    3.8 Tier 1, Tier 2 and Tier 3 Pharmaceutical Grade Xanthan Gum Players in Global Market<br />
        3.8.1 List of Global Tier 1 Pharmaceut</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/235507/pharmaceutical-grade-xanthan-gum-market">
            https://www.24chemicalresearch.com/reports/235507/pharmaceutical-grade-xanthan-gum-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>